SNL BioSolutions ApS: Financial statements 2024
CVR: 44569272
Source: annual report 2024, Danish Business Authority
17/01/2024 – 31/12/2024
SNL BioSolutions ApS (CVR 44569272) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,543,476 and a net result of DKK -3,896,480. Equity in the 2024 report amounted to DKK -3,850,164. The company had 6 employees in the financial year.
- Gross Profit
- DKK -1,543,476
- Profit/Loss
- DKK -3,896,480
- Equity
- DKK -3,850,164
- Total Assets
- DKK 880,981
- Employees
- 6
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 3, 2024, Jarne Elleholm has joined the board of directors of SNL BioSolutions ApS.
As of December 3, 2024, Dayanand Suryabhan Jadhav has joined the board of directors of SNL BioSolutions ApS.
As of January 17, 2024, Dayanand Suryabhan Jadhav is registered as director of SNL BioSolutions ApS.
SNL BioSolutions ApS was founded on January 17, 2024.
About SNL BioSolutions ApS
SNL BioSolutions ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dayanand Suryabhan Jadhav. The board consists of Dayanand Suryabhan Jadhav. The company is owned by SNLB Holding ApS. According to the 2025 annual report, the company had an average of 3 employees. In 2025, the company reported a gross profit of DKK -606,994 and a net result of DKK -1,756,475 compared with DKK -3,896,480 the year before. Equity in the 2025 report amounted to DKK -4,706,639.